Oral yolla alndnda, byk bir ksm midede paralanr ve kana karmadan etkisini yitirir
10.1016/j.bbrc.2024.149882 51 MederackeI.FilliolA.AffoS.NairA.HernandezC.SunQ.et al (2022)
10.1111/j.15720241.1998.00139.x 50 GalvanoF.FauciL
Nausea, vomiting, dyspepsia, or abdominal distension in those taking GLP-1 agonists predict increased residual gastric contents
Summary Keywords IBD, GLP-1, GLP-1 receptor agonists, diabetes, obesity Citation Migliorisi G, Gabbiadini R, Dal Buono A, Ferraris M, Privitera G, Petronio L, Bertoli P, Bezzio C and Armuzzi A (2025) GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammation
A brief spike to 100 degrees Fahrenheit may cause less damage than a sustained 85-degree exposure over multiple days, depending on the formulation and stabilizers involved